Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Prof Nurs ; 35(2): 89-92, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30902411

RESUMO

Nursing science is a diverse field of study, the scope of which has broadened to more fully incorporate genetics and genomics. In recent years, these topics have become focus areas for many nursing researchers. However, recent evidence suggests that doctoral level nursing students and nursing faculty may be underprepared to conduct independent research using genomic approaches. Furthermore, genetics and genomics are severely underrepresented in doctoral level nursing curricula across the United States. This article suggests a thorough, yet manageable three-part curriculum designed to educate doctoral level nursing students on genetics, genomics, and their use in nursing science. Recommendations are then given for the integration of the curriculum into existing nursing PhD programs.


Assuntos
Currículo , Educação de Pós-Graduação em Enfermagem , Genética/educação , Genômica/educação , Pesquisa em Enfermagem , Humanos , Estudantes de Enfermagem , Estados Unidos
2.
J Cyst Fibros ; 18(1): 127-134, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-29937318

RESUMO

BACKGROUND: Pulmonary disease remains the primary cause of morbidity and mortality for individuals with cystic fibrosis (CF). Variants at a locus on the X-chromosome containing the type 2 angiotensin II receptor gene (AGTR2) were identified by a large GWAS as significantly associating with lung function in CF patients. We hypothesized that manipulating the angiotensin-signaling pathway may yield clinical benefit in CF. METHODS: Genetic subset analysis was conducted on a local CF cohort to extend the GWAS findings. Next, we evaluated pulmonary function in CF mice with a deleted AGTR2 gene, and in those who were given subcutaneous injections of PD123,319, a selective AGTR2 antagonist for 12 weeks beginning at weaning. RESULTS: The genetic subset analysis replicated the initial GWAS identified association, and confirmed the association of this locus with additional lung function parameters. Studies in genetically modified mice established that absence of the AGTR2 gene normalized pulmonary function indices in two independent CF mouse models. Further, we determined that pharmacologic antagonism of AGTR2 improved overall pulmonary function in CF mice to near wild-type levels. CONCLUSIONS: These results identify that reduced AGTR2 signaling is beneficial to CF lung function, and suggest the potential of manipulating the angiotensin-signaling pathway for treatment and/or prevention of CF pulmonary disease. Importantly, the beneficial effects were not CF gene mutation dependent, and were able to be reproduced with pharmacologic antagonism. As there are clinically approved drugs available to target the renin-angiotensin signaling system, these findings may be quickly translated to human clinical trials.


Assuntos
Fibrose Cística/genética , DNA/genética , Pneumopatias/prevenção & controle , Pulmão/fisiopatologia , Mutação , Receptor Tipo 2 de Angiotensina/genética , Bloqueadores do Receptor Tipo 2 de Angiotensina II/farmacologia , Animais , Criança , Fibrose Cística/complicações , Fibrose Cística/metabolismo , Análise Mutacional de DNA , Modelos Animais de Doenças , Feminino , Seguimentos , Fluxo Expiratório Forçado/fisiologia , Genótipo , Humanos , Imidazóis/farmacologia , Pneumopatias/etiologia , Pneumopatias/genética , Masculino , Camundongos , Camundongos Knockout , Piridinas/farmacologia , Receptor Tipo 2 de Angiotensina/efeitos dos fármacos , Receptor Tipo 2 de Angiotensina/metabolismo , Estudos Retrospectivos
3.
J Cyst Fibros ; 15(6): 736-744, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27231029

RESUMO

BACKGROUND: Altered pulmonary function is present early in the course of cystic fibrosis (CF), independent of documented infections or onset of pulmonary symptoms. New initiatives in clinical care are focusing on detection and characterization of preclinical disease. Thus, animal models are needed which recapitulate the pulmonary phenotype characteristic of early stage CF. METHODS: We investigated young CF mice to determine if they exhibit pulmonary pathophysiology consistent with the early CF lung phenotype. Lung histology and pulmonary mechanics were examined in 12- to 16-week-old congenic C57bl/6 F508del and R117H CF mice using a forced oscillation technique (flexiVent). RESULTS: There were no significant differences in the resistance of the large airways. However, in both CF mouse models, prominent differences in the mechanical properties of the peripheral lung compartment were identified including decreased static lung compliance, increased elastance and increased tissue damping. CF mice also had distal airspace enlargement with significantly increased mean linear intercept distances. CONCLUSIONS: An impaired ability to stretch and expand the peripheral lung compartment, as well as increased distances between gas exchange surfaces, were present in young CF mice carrying two independent Cftr mutations. This altered pulmonary histopathophysiology in the peripheral lung compartment, which develops in the absence of infection, is similar to the early lung phenotype of CF patients.


Assuntos
Fibrose Cística/fisiopatologia , Pulmão/fisiopatologia , Animais , Doenças Assintomáticas , Fibrose Cística/genética , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Modelos Animais de Doenças , Camundongos , Camundongos Endogâmicos C57BL , Testes de Função Respiratória/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA